{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:10:49Z","timestamp":1648825849182},"reference-count":18,"publisher":"Societas Neurologica Japonica","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2013]]},"DOI":"10.5692\/clinicalneurol.53.119","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T07:38:39Z","timestamp":1362555519000},"page":"119-124","source":"Crossref","is-referenced-by-count":0,"title":["A case of chronic active Epstein-Barr virus infection associated with recurrent cerebellar ataxia and skin eruptions"],"prefix":"10.5692","volume":"53","author":[{"given":"Katsuya","family":"Araki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsusada","family":"Okuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephe Archie","family":"Honorat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori P.","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Mizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Kimura H, Morishima T, Kanegane H, et al. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 2003;187:527-533.","DOI":"10.1086\/367988"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Fujimoto H, Asaoka K, Imaizumi T, et al. Epstein-Barr virus infections of the central nervous system. Inter Med 2003;42:33-40.","DOI":"10.2169\/internalmedicine.42.33"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kobayashi Z, Tsuchiya K, Takahashi M, et al. An autopsy of chronic active Epstein-Barr virus infection (CAEBV): Distribution of central nervous system (CNS) lesions. J Neurol 2008;275:170-177.","DOI":"10.1016\/j.jns.2008.07.035"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Cohen JI, Jaffe ES, Dale JK, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 2011;117:5835-5849.","DOI":"10.1182\/blood-2010-11-316745"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Okano M, Kawa K, Kimura H, et al. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hemato 2005;80:64-69.","DOI":"10.1002\/ajh.20398"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Wada T, Yokoyama T, Nakagawa H, et al. Flow cytometric analysis of skin blister fluid induced by mosquito bites in a patient with chronic active Epstein-Barr virus infection. Int J Hematol 2009;90:611-615.","DOI":"10.1007\/s12185-009-0442-y"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Katagiri Y, Mitsuhashi Y, Kondo S, et al. Hydroa vacciniforme-like eruptions in a patient with chronic active EB virus infection. J Dermatol 2003;30:400-404.","DOI":"10.1111\/j.1346-8138.2003.tb00406.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Ascherio A, Munger KL. Epstein-Barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol 2010;5:271-277.","DOI":"10.1007\/s11481-010-9201-3"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Pender MP, Greer JM. Immunology of multiple sclerosis. Curr Allergy Asthma Rep 2007;7:285-292.","DOI":"10.1007\/s11882-007-0043-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Lassmann H, Niedobitek G, Aloisi F, et al. Epstein-Barr virus in the multiple sclerosis brain: a controversial issue\u2014report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria. Brain 2011;134:2772-2786.","DOI":"10.1093\/brain\/awr197"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Nicholas AP, Gupta KB, McInnis C, et al. Evidence for Epstein-Barr virus autoantibodies against human brain in demyelinating encephalitis. Neuropathol Appl Neurobiol 2002;28:498-501.","DOI":"10.1046\/j.1365-2990.2002.t01-1-00429.x"},{"key":"12"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ito H, Sayama S, Irie S, et al. Antineuronal antibodies in acute cerebellar ataxia following Epstein-Barr virus infection. Neurology 1994;44:1506-1507.","DOI":"10.1212\/WNL.44.8.1506"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Uchibori A, Sakuta M, Kusunoki S, et al. Autoantibodies in postinfectious acute cerebella ataxia. Neurology 2005;65:1114-1116.","DOI":"10.1212\/01.wnl.0000178802.38268.1e"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hirai T, Kanegane H, Ito Y, et al. Case of acute cerebellar ataxia associated with primary Epstein-Barr virus infection. Pediatr Int 2010;52:e178-180.","DOI":"10.1111\/j.1442-200X.2010.03121.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Adam C, Diadori P, Schoenroth L, et al. Autoantibodies in childhood post-varicella acute cerebellar ataxia. Can J Neurol Sci 2000;27:316-320.","DOI":"10.1017\/S0317167100001074"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yamashita S, Murakami C, Izumi Y, et al. Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis. Psychiatry Clin Neurosci 1998;52:449-452.","DOI":"10.1046\/j.1440-1819.1998.00406.x"},{"key":"18"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u5c0f\u8133\u6027\u904b\u52d5\u5931\u8abf\u3068\u591a\u5f62\u7d05\u6591\u304c\u5171\u306b\u5897\u60aa\u3068\u5bdb\u89e3\u3092\u304f\u308a\u304b\u3048\u3057\u305f\u6162\u6027\u6d3b\u52d5\u6027Epstein-Barr\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e1\u4f8b"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T20:05:52Z","timestamp":1621541152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/53\/2\/53_119\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.53.119","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}